Skip to content

CareDx CDNA Price / sales

Price / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
4.4×-0.8×
Natera, Inc. logo
Natera, Inc.NTRA
11.3×+0.9×
NeoGenomics logo
NeoGenomicsNEO
1.3×-0.5×
Personalis, Inc. logo
Personalis, Inc.PSNL
10.3×+6.7×
GeneDx Holdings logo
GeneDx HoldingsWGS
4.2×-3.3×
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
5.4×+0.7×

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Calculated from CareDx’s reported figures.

Based on the most recent quarter.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's price / sales?
CareDx (CDNA) reported price / sales of 2.2× in Q1 2026.
How has CareDx's price / sales changed year-over-year?
CareDx's price / sales decreased by 24.2% year-over-year, from 2.8× to 2.2×.
What is the long-term trend for CareDx's price / sales?
Over 5 years (2020 to 2025), CareDx's price / sales has grown at a -33.7% compound annual growth rate (CAGR), from 19.9× to 2.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.